VANCOUVER, MAY 29TH 2020, 6:00AM

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reports the Company’s consolidated interim financial results for the second quarter ended March 31, 2020.

EnWave’s interim consolidated financial statements and MD&As are available on SEDAR at www.sedar.com and on the Company’s website www.enwave.net.

Key Financial Highlights for Q2 (expressed in ‘000s):

• Revenue from EnWave in Q2 2020 was $2,169 compared to $2,009 in Q2 2019, an increase of $160 or 8%. The increase in revenue was due to higher Radiant Energy Vacuum (“REV^TM”) machinery sales primarily in the food vertical.
• Revenue from NutraDried in Q2 2020 was $5,323 compared to $6,764 in Q2 2029, a decrease of $1,441 or 21%. NutraDried revenues were downwardly impacted by fewer rotations with Costco, partially offset by growth in the grocery and online channels.
• Gross margin for Q2 2020 was 25% compared to 36% for Q2 2019, with the lower gross margin driven by the change in sales mix between NutraDried’s higher margin revenues and EnWave’s typically lower margin machine sales.
• Consolidated net loss after taxes was $1,850 for Q2 2020 compared to a net loss $224 for Q2 2019. Adjusted EBITDA^(*) was negative $1,462 for Q2 2020, compared to negative $743 for Q1 2020, an increase of $719. The decrease to Adjusted EBITDA^(*) reflects investments in a larger sales and marketing function at NutraDried as part of the growth strategy for the Moon Cheese^®
• SG&A expenses (inclusive of R&D expenses) for Q2 2020 were a combined $3,835 compared to $2,502 for Q2 2019 and $4,236 for Q1 2020. SG&A expenses for Q2 2020 reflect a large investment in NutraDried’s sales and marketing function. We reduced SG&A expenses compared to Q1 2020 by a total of $401. At the end of March, the Company implemented a major cost containment plan across EnWave and NutraDried to reduce overhead while maintaining operations in response to COVID-19, which is further described below.
• Continue to maintain a strong balance sheet with a working capital surplus of $24,382 and cash position of $15,555. After implementing a significant cost containment plan at the end of March and in response to the COVID-19 pandemic, we are in a strong position to pursue growth across both segments of the business.

Impact of COVID-19 Pandemic:

As a result of the evolving COVID-19 outbreak that was declared a global pandemic by the World Health Organization on March 11, 2020, we have implemented a number of changes to how we work to protect the health and safety of our employees and their families. Starting in mid-March, all office staff that can complete their jobs remotely have been required to work from home until further notice. All essential staff within our operations have been supplied with and required to wear personal protective equipment, are following strict physical distancing requirements and we have instituted workplace sanitation procedures to prevent against the spread of COVID-19. To-date, both EnWave and NutraDried have maintained manufacturing operations without interruption.

The international travel restrictions imposed globally to contain the spread of the virus has had a material impact on EnWave’s international operations. EnWave’s business requires staff to travel internationally to procure new license agreements and to complete large-scale REV™ machine installations and training. Due to COVID-19, our ability to meet with prospective global partners and to complete the installations of additional royalty-bearing REV™ machines has been temporarily impaired. That being stated, our technical team has successfully developed remote installation and training programs for our 10kW REV™ machinery to mitigate the impact, but prolonged international travel restrictions will impact our ability to conduct our business.

COVID-19 has had an impact on the distribution channels for NutraDried’s products. Several states in the U.S. have issued stay-at-home orders, leading many non-essential retailers to close in following these orders, thus disrupting NutraDried’s distribution logistics. A number of NutraDried’s retail customers have closed stores temporarily, including all U.S. Starbucks locations, which has impacted purchase order volumes and patterns. Many retailers in the U.S. have been addressing supply chain issues with existing products and have put category reviews and new product evaluations temporarily on hold due to COVID-19. In the current environment, COVID-19 has challenged our ability to secure meetings with buyers to gain new points of distribution for Moon Cheese^®, which causes delays in securing new distribution for the product.

The extent to which COVID-19 may impact our business will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the geographic spread of the disease, the duration of the outbreak, business closures and disruptions, public health restrictions on travel and in-person interactions and the effectiveness of actions to contain the virus. We cannot presently predict with accuracy the duration, scope, or overall impact of COVID-19 on our business over time.

Cost Containment Strategy:

The negative impact of the COVID-19 pandemic and the macroeconomic conditions which we now face have influenced the Company to implement a significant cost containment strategy to preserve liquidity and reduce non-essential expenses across both business segments. Some of the policies and actions taken at the end of March 2020 include:

• Reduced headcount across EnWave and NutraDried for a combined total of 36 fewer FTEs, consisting of 19 NutraDried production positions and 17 EnWave positions from manufacturing and SG&A functions. We have re-prioritized the remaining roles within the business to continue to execute on our strategies.
• Eliminated the use of contractors and in-sourced several functions that were previously managed by external contractors to reduce expenses.
• Minimized the use of professional services and consultants and now require approval from the executive office for the use of any critical professional services or consulting services.
• Sub-leasing of under-utilized warehouse space at EnWave to reduce monthly fixed overhead.
• Cancelled all in-person tradeshow attendance for the remainder of 2020 and eliminated all international business travel expenses across the business.
• Reduced NutraDried’s marketing programming budget for the balance of the year and reallocated the reduced budget to channels expected to yield near-term results.

As a result of these cost containment strategies implemented starting in Q3 2020, the Company has reduced expenses (at an annual run rate) by approximately $4.7 million. EnWave has reduced annual expenses at a run rate of $1.9 million and NutraDried has reduced expenses at an annual run-rate of $2.8 million. The reductions have been made across all business functions, with approximately $1.9 million from functions relate to direct costs and $2.8 million out of SG&A functions. The reduction of expenses combined with the re-prioritization of the Company’s internal resources should allow for improved financial liquidity and has right-sized the level of overhead expenses in response to the macroeconomic environment.

Q2 Significant Accomplishments:

Significant accomplishments made during Q2 2020 and to the date of this report include:

• Signed a royalty-bearing commercial license agreement with KL Ballantyne Pty Ltd (“Ballantyne”), a leading family-owned Australian diary producer. Ballantyne purchased a 10kW REV™ machine to initiate commercial production of several dairy ingredients and products developed for business to business sales in Australia and internationally.
• Signed a royalty-bearing commercial license agreement with Pacifico Snacks S.A.S. (“Pacifico Snacks”) and received a purchase order for a 10kW machine. Pacifico Snacks is a woman-owned Columbian producer of natural snacks with distribution to specialty retailers and for private label in North America. Pacifico plans to launch mango, pineapple and banana products using REV™ in 2020.
• Completed the installation of the third 120kW REV™ processing line for Milne MicroDried, our royalty partner in Idaho, U.S. Milne MicroDried produces a variety of premium quality dried fruit and vegetable products using EnWave’s technology, primarily for business to business sales, and pays EnWave a royalty based on a percentage of revenue generated from REV™ product sales.
• Signed a technology license and joint development agreement (the “JDA”) with GEA Lyophil GmbH, a global manufacturer and marketer of freeze-dry units for the pharmaceutical and biotech industries, to accelerate the potential commercialization of REV™ technology in the pharmaceutical industry.
• Entered into four new Technology Evaluation and License Option Agreements with companies that will rent 10kW REV™ machinery to evaluate the commercialization of new and innovative products that leverage the Company’s patented dehydration technology.
• Announced plans to begin the commercial deployment of REV™ technology into the U.S. cannabis vertical and are in talks with numerous U.S. cannabis companies to advance the development of this new market.
• Re-launched the Moon Cheese^® brand with vastly improved packaging, branding, consumer messaging and digital assets. Moon Cheese^® is now available in 10oz, 2oz and 1oz package sizes that have been customized to suit specific channels of distribution.
• Launched three new Moon Cheese^® flavors: Bacon Cheddar, Garlic Parmesan and White Cheddar with Black Pepper.
• Redesigned the mooncheese.com website to be more interactive and consumer friendly, and more effective in communicating our core advantages, with a focus on growing the high-margin online sales of Moon Cheese^®.

^(*) Non-IFRS Financial Measures:

Adjusted EBITDA is not a measure of financial performance under IFRS. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring impairment, restructuring, and severance charges. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the discussion included in the Company’s interim MD&A for the six months ended March 31, 2020.

DOWNLOAD THIS RELEASE

Acerca de EnWave

EnWave Corporation, una empresa de tecnología avanzada con sede en Vancouver, ha desarrollado Radiant Energy Vacuum ("REV™"), un innovador método patentado para la deshidratación precisa de materiales orgánicos. La viabilidad comercial de la tecnología REV™ ha quedado demostrada y está creciendo rápidamente en varios mercados verticales de los sectores alimentario, del cannabis legal y farmacéutico. La estrategia de EnWave consiste en firmar licencias comerciales con regalías con líderes de la industria en múltiples verticales para el uso de la tecnología REV™. Hasta la fecha, la empresa ha firmado más de veinte licencias, abriendo ocho sectores distintos del mercado a la comercialización de productos nuevos e innovadores. Además de estas licencias, EnWave ha constituido una sociedad de responsabilidad limitada, NutraDried LLP, para desarrollar, fabricar, comercializar y vender productos de aperitivo de queso totalmente naturales en Estados Unidos bajo la marca Moon Cheese®.

EnWave ha introducido REV™ como el nuevo estándar de deshidratación en los sectores alimentario y de materiales biológicos: más rápido y barato que la liofilización, con mejor calidad del producto final que el secado al aire o el secado por pulverización. En la actualidad, EnWave cuenta con tres plataformas comerciales REV™:
1. nutraREV®, que se utiliza en la industria alimentaria para secar productos alimenticios rápidamente y a bajo coste, manteniendo altos niveles de nutrición, sabor, textura y color; y
2. quantaREV®, que se utiliza para el secado continuo de gran volumen a baja temperatura.

Para más información sobre EnWave, visite www.enwave.net.

EnWave Corporation
Dr. Tim Durance
Presidente y Consejero Delegado

Para más información:
John Budreski, Presidente Ejecutivo, +1 (416) 930-0914
Correo electrónico: jbudreski@enwave.net

Brent Charleton, Vicepresidente Senior de Ventas y Desarrollo Comercial, +1 (778) 378-9616
Correo electrónico: bcharleton@enwave.net

Deborah Honig, Desarrollo Corporativo, Adelaide Capital Markets en el + 1 (647) 203-8793
Correo electrónico: dhonig@enwave.net

Safe Harbour para declaraciones de información prospectiva: Este comunicado de prensa puede contener información prospectiva basada en las expectativas, estimaciones y proyecciones de la dirección. Todas las declaraciones que se refieran a expectativas o proyecciones sobre el futuro, incluidas las declaraciones sobre la estrategia de crecimiento de la empresa, el desarrollo de productos, la posición en el mercado, los gastos previstos y las sinergias esperadas tras el cierre son declaraciones prospectivas. No se garantiza la exactitud de todas las afirmaciones de terceros a las que se hace referencia en este comunicado. No se garantiza la exactitud de todas las referencias de terceros a información de mercado contenidas en este comunicado, ya que la empresa no ha llevado a cabo la investigación primaria original. Estas afirmaciones no constituyen una garantía de resultados futuros e implican una serie de riesgos, incertidumbres y suposiciones. Aunque la empresa ha intentado identificar los factores importantes que podrían hacer que los resultados reales difirieran materialmente, puede haber otros factores que hagan que los resultados no sean los previstos, estimados o deseados. No puede garantizarse que tales afirmaciones resulten exactas, ya que los resultados reales y los acontecimientos futuros podrían diferir sustancialmente de los previstos en dichas afirmaciones. En consecuencia, los lectores no deben depositar una confianza indebida en las declaraciones prospectivas.

Ni la TSX Venture Exchange ni su Proveedor de Servicios de Regulación (según se define este término en las políticas de la TSX Venture Exchange) aceptan responsabilidad alguna por la adecuación o exactitud de este comunicado.